PL371272A1 - Benzoimidazole użyteczne w leczeniu zaburzeń funkcji seksualnych - Google Patents
Benzoimidazole użyteczne w leczeniu zaburzeń funkcji seksualnychInfo
- Publication number
- PL371272A1 PL371272A1 PL02371272A PL37127202A PL371272A1 PL 371272 A1 PL371272 A1 PL 371272A1 PL 02371272 A PL02371272 A PL 02371272A PL 37127202 A PL37127202 A PL 37127202A PL 371272 A1 PL371272 A1 PL 371272A1
- Authority
- PL
- Poland
- Prior art keywords
- sexual dysfunction
- benzimidazoles
- useful
- treating sexual
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/14—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Addiction (AREA)
- Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Pregnancy & Childbirth (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Discharging, Photosensitive Material Shape In Electrophotography (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80353701A | 2001-03-09 | 2001-03-09 | |
| US09/874,484 US20030008878A1 (en) | 2001-03-09 | 2001-06-05 | Benzimidazoles that are useful in treating sexual dysfunction |
| US10/017,939 US20020169166A1 (en) | 2001-03-09 | 2001-12-14 | Benzimidazoles that are useful in treating sexual dysfunction |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL371272A1 true PL371272A1 (pl) | 2005-06-13 |
Family
ID=27360930
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL02371272A PL371272A1 (pl) | 2001-03-09 | 2002-03-06 | Benzoimidazole użyteczne w leczeniu zaburzeń funkcji seksualnych |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20020169166A1 (pl) |
| EP (1) | EP1373220B1 (pl) |
| JP (1) | JP2005507370A (pl) |
| CN (1) | CN100430383C (pl) |
| AT (1) | ATE363474T1 (pl) |
| AU (1) | AU2002303128B2 (pl) |
| BG (1) | BG108230A (pl) |
| BR (1) | BR0205812A (pl) |
| CA (1) | CA2439943A1 (pl) |
| CZ (1) | CZ20032659A3 (pl) |
| DE (1) | DE60220385T2 (pl) |
| DK (1) | DK1373220T3 (pl) |
| ES (1) | ES2287278T3 (pl) |
| HK (1) | HK1062174A1 (pl) |
| HU (1) | HUP0303413A3 (pl) |
| IL (1) | IL157457A0 (pl) |
| MX (1) | MXPA03008151A (pl) |
| NO (1) | NO326686B1 (pl) |
| NZ (1) | NZ527713A (pl) |
| PL (1) | PL371272A1 (pl) |
| SK (1) | SK12612003A3 (pl) |
| UY (1) | UY27203A1 (pl) |
| WO (1) | WO2002088093A1 (pl) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7022728B2 (en) | 2001-03-09 | 2006-04-04 | Abbott Laboratories | Benzimidazoles that are useful in treating male sexual dysfunction |
| US6960589B2 (en) * | 2001-03-09 | 2005-11-01 | Abbott Laboratories | Benzimidazoles that are useful in treating sexual dysfunction |
| US20040127504A1 (en) * | 2002-09-06 | 2004-07-01 | Cowart Marlon D. | Benzimidazoles that are useful in treating sexual dysfunction |
| US7335658B2 (en) | 2003-07-30 | 2008-02-26 | Xenon Pharmaceuticals Inc. | Pyridazine derivatives and their use as therapeutic agents |
| US7605161B2 (en) * | 2003-07-30 | 2009-10-20 | Xenon Pharmaceuticals Inc. | Pyridyl derivatives and their use as therapeutic agents |
| AR045496A1 (es) | 2003-08-29 | 2005-11-02 | Schering Corp | Analolgos de benzimidazolpiperidinas 2- substiyuidas como antagonistas de los receptores de la hormona que concentra melanina selectivos para el tratamiento de la obesidad y trastornos relacionados |
| BRPI0515500A (pt) | 2004-09-20 | 2008-07-29 | Xenon Pharmaceuticals Inc | derivados piridazina para inibição de estearoil-coa-desaturase |
| AR051092A1 (es) | 2004-09-20 | 2006-12-20 | Xenon Pharmaceuticals Inc | Derivados heterociclicos y su uso como inhibidores de la estearoil-coa |
| AU2005329423A1 (en) | 2004-09-20 | 2006-09-28 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors |
| EP1799668A1 (en) | 2004-09-20 | 2007-06-27 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as mediators of stearoyl-coa desaturase |
| JP5043668B2 (ja) | 2004-09-20 | 2012-10-10 | ゼノン・ファーマシューティカルズ・インコーポレイテッド | 複素環誘導体および治療薬としてのそれらの使用 |
| BRPI0515489A (pt) | 2004-09-20 | 2008-07-29 | Xenon Pharmaceuticals Inc | derivados heterocìclicos e sua utilização como inibidores de estearoil-coa desaturase |
| US7919496B2 (en) | 2004-09-20 | 2011-04-05 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-CoA desaturase enzymes |
| CN101208089A (zh) | 2005-06-03 | 2008-06-25 | 泽农医药公司 | 氨基噻唑衍生物作为人硬酯酰-CoA去饱和酶抑制剂 |
| WO2008079945A2 (en) * | 2006-12-20 | 2008-07-03 | University Of South Florida | Rock inhibitors and uses thereof |
| EP2149373A1 (en) * | 2008-08-01 | 2010-02-03 | Laboratorios Del. Dr. Esteve, S.A. | 5HT7 receptor ligands and compositions comprising the same |
| EP2545905A1 (en) | 2011-07-11 | 2013-01-16 | Britannia Pharmaceuticals Limited | A new therapeutical composition containing apomorphine as active ingredient |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3362956A (en) * | 1965-08-19 | 1968-01-09 | Sterling Drug Inc | 1-[(heterocyclyl)-lower-alkyl]-4-substituted-piperazines |
| FR2665161B1 (fr) * | 1990-07-26 | 1992-11-27 | Esteve Labor Dr | Nouveaux derives de benzimidazole, leur preparation et leur application en tant que medicaments. |
| GB9306578D0 (en) * | 1993-03-30 | 1993-05-26 | Merck Sharp & Dohme | Therapeutic agents |
| WO1997024334A1 (fr) * | 1995-12-28 | 1997-07-10 | Fujisawa Pharmaceutical Co., Ltd. | Derives du benzimidazole |
| GB9700878D0 (en) * | 1997-01-17 | 1997-03-05 | Scherer Ltd R P | Dosage forms and method for ameliorating male erectile dysfunction |
| CA2251255A1 (en) * | 1998-10-20 | 2000-04-20 | Mcgill University | The use of dopaminergic agents in the management of sexual dysfunction |
| ES2154605B1 (es) * | 1999-09-14 | 2001-11-16 | Univ Madrid Complutense | Nuevos derivados mixtos de bencimidazol-arilpiperazina con afinidad por los receptores serotoninergicos 5-ht1a y 5-ht3 |
-
2001
- 2001-12-14 US US10/017,939 patent/US20020169166A1/en not_active Abandoned
-
2002
- 2002-03-06 WO PCT/US2002/007791 patent/WO2002088093A1/en active Application Filing
- 2002-03-06 CN CNB028093828A patent/CN100430383C/zh not_active Expired - Fee Related
- 2002-03-06 HU HU0303413A patent/HUP0303413A3/hu unknown
- 2002-03-06 AT AT02731130T patent/ATE363474T1/de not_active IP Right Cessation
- 2002-03-06 NZ NZ527713A patent/NZ527713A/en unknown
- 2002-03-06 EP EP02731130A patent/EP1373220B1/en not_active Expired - Lifetime
- 2002-03-06 PL PL02371272A patent/PL371272A1/pl not_active Application Discontinuation
- 2002-03-06 ES ES02731130T patent/ES2287278T3/es not_active Expired - Lifetime
- 2002-03-06 BR BR0205812-0A patent/BR0205812A/pt not_active IP Right Cessation
- 2002-03-06 JP JP2002585395A patent/JP2005507370A/ja active Pending
- 2002-03-06 IL IL15745702A patent/IL157457A0/xx unknown
- 2002-03-06 CA CA002439943A patent/CA2439943A1/en not_active Abandoned
- 2002-03-06 DE DE60220385T patent/DE60220385T2/de not_active Expired - Lifetime
- 2002-03-06 AU AU2002303128A patent/AU2002303128B2/en not_active Ceased
- 2002-03-06 DK DK02731130T patent/DK1373220T3/da active
- 2002-03-06 SK SK1261-2003A patent/SK12612003A3/sk not_active Application Discontinuation
- 2002-03-06 CZ CZ20032659A patent/CZ20032659A3/cs unknown
- 2002-03-06 MX MXPA03008151A patent/MXPA03008151A/es active IP Right Grant
- 2002-03-11 UY UY27203A patent/UY27203A1/es not_active Application Discontinuation
-
2003
- 2003-09-08 NO NO20033959A patent/NO326686B1/no not_active IP Right Cessation
- 2003-10-03 BG BG108230A patent/BG108230A/bg unknown
-
2004
- 2004-06-30 HK HK04104714A patent/HK1062174A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20033959L (no) | 2003-11-10 |
| CZ20032659A3 (cs) | 2004-01-14 |
| CN100430383C (zh) | 2008-11-05 |
| BG108230A (bg) | 2005-04-30 |
| HUP0303413A3 (en) | 2007-08-28 |
| BR0205812A (pt) | 2005-05-03 |
| HK1062174A1 (en) | 2004-10-21 |
| DE60220385T2 (de) | 2008-04-03 |
| DK1373220T3 (da) | 2007-10-08 |
| WO2002088093A1 (en) | 2002-11-07 |
| UY27203A1 (es) | 2002-10-31 |
| AU2002303128B2 (en) | 2007-11-29 |
| NO326686B1 (no) | 2009-01-26 |
| ES2287278T3 (es) | 2007-12-16 |
| IL157457A0 (en) | 2004-03-28 |
| CN1516693A (zh) | 2004-07-28 |
| CA2439943A1 (en) | 2002-11-07 |
| US20020169166A1 (en) | 2002-11-14 |
| NO20033959D0 (no) | 2003-09-08 |
| SK12612003A3 (sk) | 2004-04-06 |
| ATE363474T1 (de) | 2007-06-15 |
| DE60220385D1 (de) | 2007-07-12 |
| EP1373220B1 (en) | 2007-05-30 |
| NZ527713A (en) | 2006-09-29 |
| JP2005507370A (ja) | 2005-03-17 |
| MXPA03008151A (es) | 2004-03-16 |
| HUP0303413A2 (hu) | 2004-01-28 |
| EP1373220A1 (en) | 2004-01-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2003099266A3 (en) | Acetamides and benzamides that are useful in treating sexual dysfunction | |
| IL157457A0 (en) | Benzimidazoles that are useful in treating sexual dysfuction | |
| HK1069169A1 (en) | Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors | |
| MXPA04002593A (es) | Composiciones y metodos para el diagnostico y tratamiento de tumor. | |
| MXPA03011985A (es) | Composiciones y metodos para el diagnostico y tratamiento de tumores. | |
| MXPA05005223A (es) | Diaminotriazoles utiles como inhibidores de proteinas cinasas. | |
| TW200505903A (en) | CGRP receptor antagonists | |
| MXPA02011425A (es) | Derivados sustituidos de pirrolopiridinona utiles como inhibidores de fosfodiesterasa. | |
| MXPA03001645A (es) | Composiciones y metodos para el diagnostico y tratamiento de tumores. | |
| TW200504034A (en) | Therapeutic agents | |
| RS20050070A (en) | Use of 1kb kinase inhibitors for the treatment of pain | |
| YU75603A (sh) | Dihidropirimidinska jedinjenja koja su supstituisana na cijano grupi i njihova upotreba u lečenju oboljenja | |
| BG108180A (en) | Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases | |
| EP1546182A4 (en) | COMPOSITIONS AND METHOD FOR DIAGNOSING AND TREATING TUMORS | |
| MXPA03001643A (es) | Composiciones y metodos para el diagnostico y tratamiento de tumores. | |
| EP1511472A4 (en) | USEFUL COMPOUNDS FOR THE TREATMENT OF ANTHRAX AND INHIBITION OF THE LETAL FACTOR | |
| BR0305708A (pt) | Derivados de benzimidazol para o tratamento de disfunção sexual | |
| MXPA03004547A (es) | Agonistas receptores de d4 de dopamina selectivos para el tratamiento de disfuncion sexual. | |
| MXPA05011699A (es) | Inhibidores de la bomba de protones para el tratamiento de trastornos del abdomen inferior. | |
| TW200503722A (en) | Substituted 7-aza-quinazoline compounds | |
| MY139385A (en) | Benzimidazoles that are useful in treating sexual dysfunction | |
| MY139582A (en) | Benzimidazoles that are useful in treating sexual dysfunction | |
| MXPA05008293A (es) | Composiciones y metodos para el diagnostico y tratamiento de tumores. | |
| MXPA03001644A (es) | Composiciones y metodos para el diagnostico y tratamiento de tumor. | |
| TW200510374A (en) | Benzimidazoles that are useful in treating sexual dysfunction |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |